BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, February 13, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 5, 2020
View Archived Issues
Pivotal Japanese study evaluates zandelisib for indolent NHL
Read More
First-in-human data presented for BAY-1895344
Read More
Positive data from phase IIa NASH study of PXL-770
Read More
ZLY-16 shows hepatoprotective effects in mouse model of NASH
Read More
Vascular endothelial cells are active co-conspirators in metastasis
Read More
Discovery of new allosteric inhibitors of deoxyhypusine synthase
Read More
Enanta Pharmaceuticals patents new antivirals
Read More
E-Scape Bio discloses LRRK2 inhibitors
Read More
Merck & Co. identifies new HDAC inhibitors
Read More
New ENPP1 inhibitors presented by Stingray Therapeutics
Read More
Lead Discovery Center and SOTIO patent new compounds for cancer
Read More
Neural stem cells open to alternate fates
Read More
Preliminary first-in-human data presented for CLN-081
Read More
European Commission approves Crysvita for adolescents and adults with XLH
Read More
MEN-1611 plus trastuzumab +/- fulvestrant well tolerated in phase I breast cancer trial
Read More
Revelation Biosciences receives ethics committee approval for phase I study of REVTx-99 for COVID-19
Read More
Results reported from nextMONARCH and monarchE studies of abemaciclib
Read More
GB-004 advances into phase II for ulcerative colitis
Read More
Sorrento initiates phase I study of COVI-GUARD in patients with moderate COVID-19
Read More
No delay in progression of ovarian cancer seen with cancer vaccine MVA-5T4 in clinical trial
Read More
Xencor presents initial phase I data on tidutamab in neuroendocrine tumors
Read More
Ovoca's BP-101 for decreased sexual desire in women not approved in Russia
Read More
Phase IIb study of SYN-010 in IBS-C to be discontinued
Read More
Apellis advances pegcetacoplan into registrational programs for C3G/IC-MPGN and ALS
Read More
IND in effect for Fulcrum's phase I study of FTX-6058 for sickle cell disease
Read More
